Dabigatran's `Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials

Abstract

Description

Keywords

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By